Form 4 Tracker
David Shook

Chief Medical Officer · 2 filings · Latest: Jun 10, 2026

Lyell Immunopharma, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
LYEL
David ShookChief Medical OfficerJun 10, 2026
Sale
$12.641,977$25.0K20,923